Brief: Brainstorm Cell Therapeutics Files Prospectus For Offer And Sale Of Up To 2.8 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
25/06/2025 22:35
June 25 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.O: BRAINSTORM CELL THERAPEUTICS FILES PROSPECTUS FOR OFFER & SALE OF UP TO 2.8 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER - SEC FILING Source text: [ID:n0001104659-25-062607] Further company coverage: BCLI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview